Pediatrix Medical Group Inc (MD) 13F Holdings Overview (Q2 2026)

MD ranks #2098 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

303 institutions disclose a position in MD, but none treat it as a major bet — even Aristotle Capital Boston, LLC, its most concentrated holder, allocates just 0.5% of its own portfolio to it.

BlackRock has added to its MD position for two straight quarters, increasing it by $57.3M to reach $347.4M today.

Fidelity has trimmed its MD position for two straight quarters, cutting it by $33.2M while still holding $18.8M.

MD is up 1.5% today, and institutions have been net buyers of $132.9M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

MD closed its latest fiscal year with net income of $165.4M, and currently trades at a P/E of 13.8.

• Profitable — net income of $165.4M in the latest fiscal year
• Revenue declined 4.9% year over year
• Net income improved year over year, from -$99.1M to $165.4M
• Generated $271.1M in positive operating cash flow
• Current ratio of 1.66x — enough short-term assets to cover short-term liabilities
• Liabilities run 1.59x equity — within a conventional range